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INTRODUCTION
Lipocalins are small extracellular proteins that share a com-
mon cup-shaped structure consisting of an eight-stranded,
antiparallel, continuously hydrogen-bonded  -barrel (1, 2).
They provide the binding site for a range of small hydropho-
bic molecules as well as soluble macromolecules. Eventually,
the lipocalin proteins affect the transport of a variety of small
lipophilic molecules, functioning as the homeostatic regula-
tors, immunomodulators, retinol transporters, and prosta-
glandin producers (3-5). Neutrophil gelatinase-associated
lipocalin (NGAL) is one of the lipocalin family proteins, which
was originally identified as a 25-kDa protein covalently asso-
ciated with the 92-kDa neurophil gelatinase (matrix metal-
loproteinase-9 [MMP-9]) (6, 7). NGAL is capable of protect-
ing MMP-9 from degradation, thereby preserving MMP-9
enzymatic activity (8). However, NGAL can also be purified
in both a monomeric and dimeric form without gelatinase,
and is mainly exocytosed from neutrophils in forms not com-
plexed with MMP-9, indicating that both NGAL and gelati-
nase exist predominantly in forms not associated with each
other (6, 9). Evidence shows that NGAL binds to a variety
of bacterial ferric siderophores that transport iron to bacte-
ria. By taking the iron away from bacteria, NGAL acts as a
potent bacteriostatic agent under iron-limited conditions (10).
Furthermore, NGAL delivers iron to kidney cells where it
activates or represses iron-responsive genes, thereby playing
an important role in mesenchymal-epithelial transition dur-
ing development of the mammalian nephron (11).
The epidermis is a stratified tissue that is composed of pro-
genitor cells in the basal layer, differentiating keratinocytes
in the suprabasal layers, and dead, fully-differentiated cells
on the surface. These phenotypically and functionally differ-
ent cells are formed by the well-programmed gene expres-
sion changes during the terminal differentiation process (12-
14). Although a number of genes required for keratinocyte
differentiation have been already discovered, it is likely that
many important molecules remain undisclosed. In an effort
to identify the genes related to keratinocyte differentiation,
we previously performed suppression subtractive hybridiza-
tion (SSH) using a calcium-induced keratinocyte differenti-
ation model. Among the genes obtained, NGAL showed
marked induction by calcium treatment in cultured ker-
atinocytes (15). Thus, in this study, we attempted to further
verify the expression of NGAL in cultured keratinocytes as
well as in several skin diseases.
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Expression of Neutrophil Gelatinase-Associated Lipocalin in 
Calcium-Induced Keratinocyte Differentiation
In a previous search for the differentially expressed genes in keratinocyte differen-
tiation, we identified neutrophil gelatinase-associated lipocalin (NGAL) as a calci-
um-induced gene. In this study, we further verified the expression of NGAL in cul-
tured keratinocytes as well as in several skin diseases. Reverse transcription-poly-
merase chain reaction (RT-PCR), Western blot, and ELISA clearly showed that
NGAL expression was markedly increased in calcium-induced keratinocyte differ-
entiation in vitro. However, in our previous report, NGAL expression was not detect-
ed in normal skin tissue except for hair follicle by in situ hybridization and immuno-
histochemistry, indicating the difference of cell status between in vitro and in vitro
conditions. Interestingly, NGAL expression was highly increased in psoriasis-like
inflammatory disorders (lichen planus and pityriasis rubura pilaris) and skin cancers
(keratoacanthoma and squamous cell carcinoma), implying that NGAL may be relat-
ed with the epidermal hyperplasia. Collectively, these results reveal the potential impor-
tance of NGAL in the maintenance of skin homeostasis.
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MATERIALS AND METHODS
Skin samples 
All skin samples were obtained with given written informed
consent of donors, in accordance with the ethical committee
approval process of Chungnam National University Hospi-
tal. The study was conducted according to Declaration of
Helsinki Principles.
Cell culture 
Skin specimens were briefly sterilized in 70% ethanol,
minced, and then treated with dispase for overnight at 4℃.
The epidermis was separated and placed in a solution contain-
ing 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid
(EDTA) (Gibco BRL, Rockville, MD, U.S.A.) for 15 min at
37℃. After vigorous pipetting, cells were pelleted and resus-
pended in keratinocyte-serum free medium (K-SFM) supple-
mented with bovine pituitary extract and recombinant human
epidermal growth factor (Gibco BRL). Cells were grown in
collagen-coated dishes at 37℃, 5% CO2 atmosphere. At the
third passage, cells were switched to the same medium con-
taining 1.2 mM calcium and cultured for 1, 3, 7, and 14 day.
Reverse transcription-polymerase chain reaction (RT-PCR)
Two micrograms of total RNAs were reverse transcribed
with M-MLV reverse transcriptase (Promega, Madison, WI,
U.S.A.). Aliquots of RT mixture were subject to PCR cycles
with specific primer set for NGAL (5’-CAATTCCAGGG-
GAAGTGGTA and 5’-GCCTGAGGGCACATGTTTAT)
as follows: 94℃ for 30 sec, 58℃ for 30 sec, 72℃ for 1 min
for 30 cycles.
Western blot analysis 
The cell and tissue extracts were prepared using Pro-prep
protein extraction solution (Intron, Daejeon, Korea). Protein
samples were run on 15% sodium dodecyl sulfate (SDS)-
polyacrylamide gel, transferred onto nitrocellulose membrane
and incubated with anti-human NGAL polyclonal antibody.
For an internal control, anti-actin antibody (Sigma, St Louis,
MO, U.S.A.) was used. Blots were then incubated with per-
oxidase-conjugated secondary antibody and developed by
enhanced chemiluminescence (Amersham, Buckinghamshire,
U.K.).
Enzyme-linked immunosorbent assay (ELISA)
The level of NGAL in conditioned medium was quanti-
fied according to the method previously reported (16). Cells
received fresh medium daily, and NGAL secreted into the
medium was detected at the indicated time points. Measure-
ments were repeated at least three times, with independent
cell batches obtained from three different donors.
Zymography 
The gelatinase activity was assayed according to a minor
modification of the method reported previously (8). Sam-
ples of conditioned medium (40  L) were run on 10% SDS-
polyacrylamide gel containing 0.1% gelatin (Sigma), under
non-reducing condition. Following electrophoresis, SDS was
removed by washing with 2.5% Triton X-100 for 90 min
at room temperature. Substrate digestion was carried out by
incubating the gel in 50 mM Tris, pH 7.6, 10 mM CaCl2,
1 M  ZnCl2, for 24 hr at 37℃. The gel was visualized by
staining with 0.25% Coomassie Blue solution (Sigma).
Immnohistochemistry
Paraffin sections of skin specimens were dewaxed, rehy-
drated, then washed three times with phosphate-buffered
saline (PBS). After treatment with proteinase K for 5 min at
37℃, sections were treated with H2O2 for 10 min at room
temperature, blocked in 0.1% Tween-20, 1% bovine serum
albumin in PBS for 20 min, and followed by reaction with
anti-NGAL antibody for 1 hr. Sections were incubated sequen-
tially with peroxidase-conjugated secondary antibody and
visualized with Chemmate envision detection kit (Dako,
Carpinteria, CA, U.S.A.). The list of skin diseases determined
in this study are as follows; lichen planus (LP), pityriasis
rubura pilaris (PRP), pityriasis rosea (PR), keratoacanthoma
(KA), squamous cell carcinoma (SCC), and basal cell carci-
noma (BCC). At least three samples of each disease were
analyzed, with similar results. All SCCs tested in this study
were in the state of well-differentiated. 
Statistical analysis 
Data were analyzed statistically using Student’s t-test or
one-way analysis of variance followed by Fisher’s least signifi-
cant difference test for a post hoc comparison. The statistical
significance was set at p<0.01.
RESULTS
We previously identified NGAL as a calcium-induced gene
in cultured keratinocytes by the SSH technique (15). In this
study, we attempted to further verify whether the expression
of NGAL was related to the calcium-induced keratinocyte
differentiation in vitro. For this end, cultured normal human
epidermal keratinocytes (NHEK) were treated with 1.2 mM
calcium for the indicated time points, then the expression of
NGAL was investigated using RT-PCR and Western blot
analysis. As shown in Fig. 1A, NGAL mRNA was highly304 J.-H. Lee, K.-C. Kye, E.-Y. Seo, et al.
increased at 7 and 14 day after treatment with calcium of
keratinocytes. Western blot analysis also showed that NGAL
protein was remarkably increased by calcium treatment in a
time-dependent manner (Fig. 1B). Since NGAL is a well-
known secretory protein, we determined the secreted NGAL
by a specific ELISA method developed by Kjeldsen et al. (16).
Consistent with the Western blot data, the amount of NGAL
in conditioned medium was highly increased at the late time
points after calcium treatment (Fig. 2A). Next, we determin-
ed the MMP-9 activity in conditioned medium, as the previ-
ous report indicated that over-expression of NGAL in human
breast carcinoma cells leads to the protection of MMP-9 there-
by increasing its activity in conditioned medium (8). How-
ever, the MMP-9 activity in our system did not show signif-
icant changes (Fig. 2B), suggesting that the increased NGAL
is not associated with the MMP-9 activity in calcium-treated
keratinocytes. This result is consistent with the data by Kjeld-
sen et al. (9), which showed that NGAL can be also purified
A
Fig. 1. Expression of NGAL in normal human epidermal kerati-
nocytes cultured in vitro. (A) RT-PCR analysis. Cells were differ-
entiated by addition of 1.2 mM calcium for the indicated time points.
Two micrograms of total RNAs were reverse transcribed with M-
MLV reverse transcriptase and used for PCR amplification. GAPDH
was used as an internal control. (B) Immunoblot analysis. Cellular
proteins (20  g per lane) were separated on duplicate 15% poly-
acrylamide gels, and transferred onto nitrocellulose membranes.
Each membrane was reacted with anti-NGAL antibody, and anti-
actin antibody as a loading control, respectively.
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Fig. 2. (A) Cells received fresh medium daily and conditioned
medium were prepared. The amount of NGAL was measured by
a specific ELISA method. The results are shown as mean values
±SEM of triplicate measurements (*p<0.01 vs. control). (B) MMP-
9 activity in conditioned medium. Samples of conditioned medium
were run on 10% SDS-polyacrylamide gel containing 0.1% gelatin,
under a non-reducing condition. After substrate digestion, the MMP-
9 activity was visualized by Coomassie staining. The bands migrat-
ed to a location corresponding to a molecular mass of 92-kDa.
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Fig. 3. Immunohistochemistry analysis of NGAL expression in several skin diseases. Paraffin-embedded tissue sections of skin specimens
were stained with anti-NGAL antibody. (A) Inflammatory disorders. LP, lichen planus; PRP, pityriasis rubura pilaris; PR, pityriasis rosea. (B)
Skin cancers. KA, keratoacanthoma; SCC, squamous cell carcinoma; BCC, basal cell carcinoma.
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in both a monomeric and dimeric form without gelatinase and
is mainly exocytosed from neutrophils in forms not complexed
with MMP-9.
In this study, we attempted to further investigate the expres-
sion of NGAL in several skin diseases. These include psoria-
sis-like inflammatory disorders (LP, PRP, and PR) and skin
cancers (KA, SCC, and BCC). As shown in Fig. 3A, NGAL
expression was detected at the upper granular layer of LP
and all layers of PRP, but not in PR. These results suggest
that NGAL expression reflects the different status of inflam-
mation, and may be related with the epidermal hyperplasia.
In addition, NGAL expression was highly increased in KA
and SCC, but not in BCC (Fig. 3B), suggesting that the onset
of keratinocyte differentiation may be one trigger for high
induction of NGAL expression.
DISCUSSION
In this study, we showed that NGAL expression is highly
increased in calcium-induced keratinocyte differentiation in
vitro, and in several skin diseases such as psoriasis-like inflam-
matory disorders (LP and PRP) and skin cancers (KA and
SCC). A previous report indicates that NGAL expression is
related with the dysregulated keratinocyte differentiation.
For example, strong induction of NGAL in the epidermis
was seen in psoriasis, PRP, and SCC (17), well consistent
with our results. In addition, NGAL is highly expressed in
well-differentiated SCC of the lung, implicating that NGAL
is linked to either keratin synthesis or terminal differentia-
tion (18). However, in our previous study, NGAL expression
was not detected in atopic dermatitis, another important
skin disease characterized by disturbed terminal differentia-
tion, suggesting that increased NGAL is not tightly associ-
ated with dysregulated epithelial differentiation, but rather
relates with the different status of abnormal keratinocytes
disease by disease (19).
Although NGAL was originally identified from human
neutrophils, it is now clear that NGAL is expressed in a vari-
ety of normal and pathological human tissues including stom-
ach, liver, kidney, colon, and skin (5, 18, 20, 21). However,
the role of NGAL in several pathologic statuses largely remains
to be elucidated. Considering the potential of NGAL-bind-
ing to siderophores, thereby facilitating the iron delivery
into cells (11), it could not be ruled out the possibility that
NGAL-mediated iron delivery may have direct impact on
keratinocyte proliferation and hyperplasia. It has been known
that most cells acquire iron by receptor-mediated endocyto-
sis of iron-loaded transferring (22). Interestingly, transferrin
receptor expression is correlated with the proliferation rate,
being increased by growth stimulation or decreased by induc-
tion of terminal differentiation (23). Given that NGAL exerts
its role as an iron transporter in the epidermis, one possible
explanation for high expression in several hyperplastic and/or
hyperproliferative diseases is that it may supplement iron to
the upper layer of stratified epithelium. That is, keratinocytes
would require more iron delivered by transporters during the
hyperproliferation, since the quantity of iron delivered by
transferrin is probably insufficient to support cell prolifera-
tion. The precise relationship between iron supply and NGAL
expression in epidermis, however, remains to be elucidated.
In summary, we showed that NGAL expression was in-
creased in calcium-induced keratinocyte differentiation, and
in several hyperplastic and/or hyperproliferative skin diseases,
suggesting that NGAL may have a role in the maintenance
of skin homeostasis.
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